STIPULATION & [PROPOSED] ORDER TO POSTPONE CASE MANAGEMENT CONFERENCE PENDING RESOLUTION OF ARBITRATION

EDWARD M. CHEN, District Judge.

Plaintiff AbbVie, Inc. ("AbbVie"), Defendant Novartis Vaccines and Diagnostics, Inc., ("Novartis"), and Defendant Grifols Worldwide Operations Ltd. ("Grifols") file this stipulated request and respectfully ask the Court to modify the case schedule to postpone the Initial Case Management Conference and due date for the Case Management Statement, pending resolution of arbitration between AbbVie and Novartis.

On August 31, 2017, this Court granted Defendant's Motion to Compel Arbitration. (D.I. 73.) In response, AbbVie and Novartis commenced arbitration. The arbitration proceedings are on-going.

A Case Management Conference is currently scheduled for February 1, 2018, with a Case Management Statement due on January 25, 2018. (D.I. 76.)

In view of the foregoing, and to avoid unnecessary expenditure of judicial resources, the parties concur that good cause exists to stay upcoming deadlines in this case pending resolution of the arbitration proceedings. Therefore, the parties request that the Court postpone the Case Management Conference and reset the due date for the Case Management Statement to correspond with that rescheduled Conference. The parties will inform the Court when arbitration is concluded, so that any appropriate schedule can be entered.

WHEREFORE, the parties respectfully request that, for good cause shown, the Court grant this stipulated request.

SIGNATURE ATTESTATION

Pursuant to Local Rule 5-1(i)(3), I hereby attest that concurrence in filing has been obtained from Michael A. Morin, Thomas P. Steindler, and Andrea Meghrouni-Brown indicated by a "conformed" signature (/s/) within this e-filed document.

[PROPOSED] ORDER

Pursuant to Stipulation, the Clerk's Notice dated August 31, 2017 (ECF No. 76) setting a date for the Case Management Conferences is hereby VACATED. reset for 3/29/18 at 9:a.m.